I85PREP
⌘ K
EHPLE Pharmacy study materials
EHPLE Pharmacy study resources

EHPLE Pharmacy practice questions

One question at a time. Build your EHPLE Pharmacy understanding.

First 50 of 190 questions. Each one lists the choices, the correct answer, and an explanation. The checker at the top of this page saves progress in this browser when it is available.

Continue in the practice tool above to load more questions, 50 at a time.

Question 1Pharmacodynamic targets, class effects and therapeutic limits

Which adrenergic receptor subtype is predominantly located on bronchial smooth muscle and vascular smooth muscle of skeletal muscle, mediating relaxation and bronchodilation upon activation (支气管平滑肌舒张)?

  1. Alpha-1 adrenergic receptor (α1受体)
  2. Beta-1 adrenergic receptor (β1受体)
  3. Alpha-2 adrenergic receptor (α2受体)
  4. Beta-2 adrenergic receptor (β2受体) Correct answer.

Explanation

Beta-2 adrenergic receptors (β2受体) are coupled to Gs proteins, stimulating adenylate cyclase to increase intracellular cAMP, which activates protein kinase A (PKA) and promotes smooth muscle relaxation. Activation of β2 receptors produces bronchodilation, vasodilation in skeletal muscle vascular beds, and glycogenolysis in the liver.

Question 2Pharmacodynamic targets, class effects and therapeutic limits

Which biochemical pathway and specific fungal enzyme are targeted by triazole antifungal agents such as fluconazole and voriconazole (三唑类抗真菌药作用靶点)?

  1. Inhibition of squalene epoxidase in squalene pathway
  2. Inhibition of cytochrome P450-dependent Lanosterol 14α-demethylase (CYP51 / 羊毛甾醇14α-去甲基酶) Correct answer.
  3. Inhibition of β-(1,3)-D-glucan synthase in cell wall assembly
  4. Inhibition of fungal DNA topoisomerase II

Explanation

Azole antifungals (triazoles like fluconazole, voriconazole, itraconazole) selectively inhibit fungal cytochrome P450-dependent Lanosterol 14α-demethylase (encoded by ERG11 / CYP51). This blocks the conversion of lanosterol to ergosterol, leading to ergosterol depletion and accumulation of toxic 14α-methylated sterols that disrupt fungal membrane permeability and inhibit fungal growth.

Question 3Pharmacokinetics, therapeutic monitoring and explicit calculation models

Which of the following metabolic transformations represents a Phase II conjugation reaction (第II相结合反应) in human drug metabolism?

  1. Aromatic hydroxylation catalyzed by Cytochrome P450 3A4 (CYP3A4芳环羟基化)
  2. Ester hydrolysis catalyzed by serum carboxylesterase (酯酶水解)
  3. Sulfoxidation catalyzed by flavin-containing monooxygenase (黄素单加氧酶硫氧化)
  4. Glucuronidation catalyzed by UDP-glucuronosyltransferase (UDP-葡萄糖醛酸转移酶结合反应) Correct answer.

Explanation

Drug metabolism is divided into Phase I functionalization reactions (oxidation, reduction, hydrolysis that introduce or unmask polar functional groups like -OH, -COOH, -NH2, -SH) and Phase II conjugation reactions (结合反应), where endogenous hydrophilic molecules such as glucuronic acid, sulfate, glutathione, glycine, or acetate are covalently attached to make metabolites highly water-soluble for renal or biliary excretion.

Question 4Pharmacokinetics, therapeutic monitoring and explicit calculation models

In pharmaceutical chiral chemistry, why does Esomeprazole (艾司奥美拉唑 / S-奥美拉唑) demonstrate superior systemic bioavailability and less inter-individual pharmacokinetic variability compared to the racemic mixture Omeprazole?

  1. The (S)-enantiomer undergoes significantly lower first-pass hepatic metabolism by CYP2C19 than the (R)-enantiomer, achieving higher AUC (S-异构体受CYP2C19代谢清除率显著低于R-异构体) Correct answer.
  2. The (S)-enantiomer binds irreversibly to gastric H+/K+-ATPase whereas the (R)-enantiomer is completely inactive
  3. The (S)-enantiomer is absorbed via active peptide transporters whereas the (R)-enantiomer is not absorbed
  4. The (R)-enantiomer causes competitive inhibition of the proton pump whereas the (S)-enantiomer acts as an allosteric opener

Explanation

Esomeprazole is the S-enantiomer and has relevant metabolic differences from the racemic comparison, which can alter systemic exposure under the specified conditions. Genetics, formulation, dose and interacting medicines also affect results. A stereochemical comparison does not guarantee identical improved exposure or therapeutic benefit in every person.

Question 5Dosage forms, formulation behavior and responsible preparation

Which oral solid dosage form utilizes a semipermeable membrane coating with laser-drilled delivery orifices to achieve constant, zero-order drug release driven by internal hydrostatic osmotic pressure (渗透泵控释片)?

  1. Enteric-Coated Delayed-Release Tablet (肠溶片)
  2. Osmotic Pump Controlled-Release Tablet (渗透泵控释制剂) Correct answer.
  3. Effervescent Disintegrating Tablet (泡腾片)
  4. Erodible Matrix Sustained-Release Tablet (溶蚀性骨架片)

Explanation

Osmotic pump tablets (渗透泵制剂, e.g., Nifedipine GITS / 硝苯地平控释片) consist of an active drug core surrounded by a rigid semipermeable membrane with a laser-drilled microscopic orifice. Water from gastrointestinal fluids permeates into the core, dissolving osmotic agents and generating hydrostatic pressure that pumps drug solution out through the orifice at a steady, zero-order release rate independent of gastrointestinal pH and motility.

Question 6Dosage forms, formulation behavior and responsible preparation

In semi-solid formulation science, what type of ointment base is exemplified by hydrophilic petrolatum and anhydrous lanolin (羊毛脂), capable of absorbing substantial amounts of water while remaining non-washable with water?

  1. Water-Soluble Polyethylene Glycol Base (水溶性PEG基质)
  2. Oil-in-Water Emulsion Base (O/W型乳剂基质 / 水包油型)
  3. Oleaginous Hydrocarbon Base (单纯烃类油脂性基质)
  4. Absorption / Emulsifiable Hydrocarbon Base (吸收性软膏基质) Correct answer.

Explanation

Absorption ointment bases (吸收性基质, e.g., anhydrous lanolin / 羊毛脂, hydrophilic petrolatum) consist of hydrocarbon or lipid bases combined with W/O emulsifiers (such as sterols or cholesterol). They can absorb significant quantities of aqueous solutions to form W/O emulsions, providing occlusive emollient protection.

Question 7Pharmaceutical analysis, identity, stability and quality evidence

In pharmaceutical analytical testing under the Chinese Pharmacopoeia (《中国药典》), which quantitative principle states that absorbance (A) is directly proportional to both absorption path length (b) and solution concentration (c) in UV-Vis spectrophotometry?

  1. Nernst Distribution Law (能斯特分配定律)
  2. Bragg's Law of X-ray Diffraction (布拉格定律)
  3. Lambert-Beer Law (朗伯-比尔定律: A = εbc) Correct answer.
  4. Fick's First Law of Diffusion (菲克第一扩散定律)

Explanation

The Lambert-Beer Law (朗伯-比尔定律) is the fundamental physical law governing UV-Vis absorption spectroscopy: A = E1%1cm * c * L (or A = εbc), where A is absorbance, ε is molar absorptivity, b is the optical path length in cm, and c is molar concentration. It forms the quantitative basis for spectrophotometric drug assay content determination.

Question 8Pharmaceutical analysis, identity, stability and quality evidence

In pharmaceutical manufacturing and hospital preparation of sterile injectables, which method is widely utilized for bacterial endotoxin testing (细菌内毒素检查) based on the gelation of amoebocyte lysate from the horseshoe crab?

  1. Rabbit Pyrogen Test (家兔发热试验法)
  2. Membrane filtration bioburden sterility test (薄膜过滤法无菌检查)
  3. Limulus Amebocyte Lysate assay (TAL/LAL assay / 鲎试剂法) Correct answer.
  4. High-Performance Liquid Chromatography (高效液相色谱法)

Explanation

The Limulus Amebocyte Lysate (LAL/TAL / 鲎试剂) test is the primary, highly sensitive in vitro assay specified in the Chinese Pharmacopoeia for detecting bacterial endotoxins (LPS from Gram-negative bacteria). Endotoxins activate clotting enzyme cascades in the amebocyte lysate from Tachypleus tridentatus or Limulus polyphemus, producing a firm gel clot or optical turbidity.

Question 9Medical biology, diagnostic evidence and sample interpretation

In human cellular physiology, which transport mechanism is responsible for moving Na+ out of the cell and K+ into the cell against their respective concentration gradients, consuming ATP in the process (主动转运)?

  1. Sodium-potassium adenosine triphosphatase pump (Na+/K+-ATPase 钠钾泵) Correct answer.
  2. Voltage-gated sodium channel facilitated diffusion (电压门控钠通道易化扩散)
  3. Simple lipid bilayer passive diffusion (简单扩散)
  4. Potassium leak channel passive efflux (钾漏通道被动外流)

Explanation

Primary active transport (原发性主动转运) moves ions across the plasma membrane against electrochemical gradients using energy directly derived from ATP hydrolysis. The Na+/K+-ATPase pump expels 3 Na+ ions from the intracellular compartment in exchange for importing 2 K+ ions per ATP molecule hydrolyzed, maintaining resting membrane potential and cell volume.

Question 10Medical biology, diagnostic evidence and sample interpretation

During the action potential of ventricular cardiac working myocytes (心室肌动作电位), which ionic current is primarily responsible for the characteristic Phase 2 plateau (2期平台期)?

  1. Fast inward Na+ current via Nav1.5 channels (INa)
  2. Inward Ca2+ current via L-type calcium channels (ICa-L) balanced by delayed rectifier outward K+ current (IK) Correct answer.
  3. Transient outward K+ current (Ito)
  4. Inward rectifier K+ current maintaining resting potential (IK1)

Explanation

Phase 2 (plateau phase / 平台期) of the ventricular cardiac action potential is characterized by a balance between the slow inward flow of Ca2+ through L-type calcium channels (ICa-L) and the outward flow of K+ through delayed rectifier potassium channels (IK). This prolonged plateau prolongs the effective refractory period (ERP), preventing tetanic cardiac contraction.

Question 11Clinical pharmacy review, counseling and safe escalation

A patient with acute coronary syndrome undergoes percutaneous coronary intervention (PCI) with drug-eluting stent placement. Genetic testing reveals the patient is a CYP2C19*2/*2 homozygous loss-of-function poor metabolizer (慢代谢型). Why is Clopidogrel (氯吡格雷) ineffective in this patient, and which P2Y12 inhibitor is guideline-recommended instead?

  1. Clopidogrel is toxic to CYP2C19 poor metabolizers causing acute hemolysis; Warfarin should be substituted
  2. Clopidogrel is an inactive prodrug requiring CYP2C19 bioactivation into its active thiol metabolite; Ticagrelor (替格瑞洛) is direct-acting and independent of CYP2C19 bioactivation (氯吡格雷需CYP2C19活化，应换用直接作用的替格瑞洛) Correct answer.
  3. Clopidogrel irreversibly blocks COX-1; Aspirin monotherapy should be used instead
  4. Clopidogrel is cleared too rapidly in CYP2C19*2 carriers; doubling the clopidogrel dose is the sole guideline recommendation

Explanation

Clopidogrel is a thienopyridine prodrug that requires a two-step hepatic bioactivation process, in which CYP2C19 plays the predominant role in forming the active thiol metabolite that irreversibly blocks the platelet P2Y12 ADP receptor. CYP2C19*2 and *3 alleles encode non-functional enzymes; homozygous poor metabolizers (*2/*2) cannot form sufficient active drug, leading to high on-treatment platelet reactivity and stent thrombosis. Ticagrelor (替格瑞洛) is a cyclopentyltriazolopyrimidine that is active without metabolic bioactivation, making it the preferred first-line agent.

Question 12Clinical pharmacy review, counseling and safe escalation

Aminoglycoside antibiotics (e.g., Gentamicin, Amikacin / 庆大霉素、阿米卡星) exhibit concentration-dependent killing and a significant Post-Antibiotic Effect (PAE / 抗生素后效应). What are their two principal organ toxicities that mandate clinical therapeutic drug monitoring?

  1. Ototoxicity (vestibulocochlear damage) and Nephrotoxicity (acute tubular necrosis) (耳毒性与肾毒性) Correct answer.
  2. Hepatotoxicity and Aplastic anemia
  3. Pulmonary fibrosis and Peripheral neuropathy
  4. Retinal macular degeneration and Tendon rupture

Explanation

Aminoglycosides selectively accumulate in the perilymph/endolymph of the inner ear and the proximal tubular epithelial cells of the renal cortex. They cause Ototoxicity (耳毒性 - permanent cochlear sensory hair cell damage and vestibular dysfunction causing hearing loss, tinnitus, and ataxia) and Nephrotoxicity (肾毒性 - typically non-oliguric acute tubular necrosis with elevated serum creatinine). Both toxicities correlate with elevated trough concentrations and prolonged treatment duration.

Question 13Dispensing systems, medication reconciliation and error prevention

In patient medication safety management, what operational strategy is required for Look-Alike Sound-Alike (LASA / 听似看似易混淆药品) and High-Alert Medications (高警示药品)?

  1. Physical segregation, conspicuous high-alert warning labels, tall-man lettering on electronic interfaces, and independent double-check verification prior to dispensing (分开放置、警示标识、高警示双人复核) Correct answer.
  2. Alphabetical co-shelving to minimize dispensary retrieval transit time
  3. Permitting verbal telephone orders without written read-back confirmation
  4. Dispensing without independent secondary verification in high-volume rush periods

Explanation

Patient safety standards mandated by the NHC and the Institute for Safe Medication Practices (ISMP) require that LASA drugs (e.g., vincristine vs vinblastine, ephedrine vs epinephrine) and high-alert medications (e.g., concentrated potassium chloride, 10% NaCl, insulin, heparin) must be stored in physically segregated bins with bold colored warning labels (警示标识), utilize tall-man lettering, and undergo mandatory independent double-checking (双人核对) before dispensing.

Question 14Dispensing systems, medication reconciliation and error prevention

A clinical pharmacist auditing an inpatient prescription notices an order for '10% Potassium Chloride Injection 10 mL via Direct Intravenous Bolus (静脉推注)'. What immediate intervention is required and why?

  1. Approve the prescription provided it is administered over 2 minutes
  2. Change the route to subcutaneous injection without physician consultation
  3. Intervene immediately to intercept the order: Direct intravenous push of concentrated potassium chloride causes acute cardiac arrest and is strictly prohibited; it must be diluted into intravenous infusions to a final concentration not exceeding 0.3% w/v (严禁直接静脉推注高浓度氯化钾，可致心脏骤停，输注浓度严禁超过0.3%) Correct answer.
  4. Approve the order if the patient has documented hypokalemia

Explanation

Concentrated Potassium Chloride (10% KCl) is a Class A High-Alert Medication (高警示药品). Direct intravenous push (静脉推注/静脉注射) causes sudden, massive hyperkalemia in the coronary circulation, depolarizing the cardiac resting membrane potential, abolishing cardiac automaticity and conduction, and inducing immediate fatal diastolic cardiac arrest (心脏骤停). Potassium chloride MUST be diluted in IV fluids (e.g., normal saline or 5% glucose) to a final concentration strictly ≤0.3% w/v (3 g KCl per 1000 mL fluid) and administered via controlled infusion at a rate not exceeding 20 mmol/h (1.5 g/h).

Question 15Evidence appraisal, calculations and pharmacy resource decisions

In hospital pharmacy inventory management, what is the Economic Order Quantity (EOQ / Formule de Wilson) used to determine, and how does the ABC analysis classify pharmaceutical inventory?

  1. EOQ determines the optimal order size that minimizes the sum of ordering costs and inventory holding/carrying costs; ABC analysis stratifies stock by annual consumption value (Class A = ~10–20% of items accounting for ~70–80% of total budget) Correct answer.
  2. EOQ calculates drug expiration dates; ABC analysis classifies drugs alphabetically by brand name
  3. EOQ determines the lethal dose 50 of toxic waste; ABC analysis sorts medicines by tablet shape
  4. EOQ calculates nurse salary deductions; ABC analysis sorts products by package weight

Explanation

The Wilson formula calculates the Economic Order Quantity: EOQ = sqrt((2 × Annual Demand × Ordering Cost) / Holding Cost per unit). ABC analysis applies Pareto's 80/20 principle to hospital pharmacy management: Class A items (high financial value, ~70–80% of expenditure, ~10–20% of line items) receive rigorous daily inventory control; Class B items (intermediate, ~15–20% value); Class C items (low financial value, ~5–10% value, ~60–70% of line items).

Question 16Pharmacy qualification roles, scientific references and local duties

In clinical pharmacy and patient safety, what is Medication Reconciliation (Conciliation des traitements médicamenteux / Medication reconciliation), and at what clinical transition points should it be systematically performed?

  1. A formal multidisciplinary process where the clinical pharmacist compiles the exhaustive Best Possible Medication History (BPMH) and compares it with active hospital prescriptions to detect and intercept unintended discrepancies, omissions, and duplications at hospital admission, intra-hospital transfer, and discharge Correct answer.
  2. A billing audit performed by hospital accounting at patient discharge
  3. Verification that the brand names match the hospital formulary exclusively
  4. A laboratory test measuring all drug concentrations in blood simultaneously

Explanation

Medication reconciliation (conciliation médicamenteuse) is a formalized patient safety process led by clinical pharmacists. By interviewing the patient, family, community pharmacist, and attending physician, the pharmacist establishes the Best Possible Medication History (BPMH / Bilan Médicamenteux Optimisé) and cross-references it with current hospital orders, identifying and correcting unintended discrepancies (omitted chronic therapies, dosing errors, duplicates) at admission, ward transfer, and discharge.

Question 17Pharmacodynamic targets, class effects and therapeutic limits

Which pharmacological mechanism explains the clinical action of atropine in reversing organophosphate-induced bradycardia and excessive secretions?

  1. Competitive antagonism of muscarinic acetylcholine receptors at parasympathetic postganglionic neuroeffector sites Correct answer.
  2. Competitive blockade of nicotinic acetylcholine receptors at neuromuscular junctions
  3. Non-competitive inhibition of acetylcholinesterase in synaptic clefts
  4. Direct stimulation of beta-1 adrenergic receptors in cardiac nodal tissue

Explanation

Atropine is a prototypical tertiary amine antimuscarinic agent that reversibly competes with acetylcholine for postganglionic muscarinic receptors (M1 through M5). By blocking parasympathetic input to the sinoatrial node and exocrine glands, it reverses life-threatening bradycardia, bronchorrhea, and bronchospasm. It does not bind to nicotinic receptors at therapeutic concentrations and has no direct effect on beta-adrenergic receptors.

Question 18Pharmacodynamic targets, class effects and therapeutic limits

A patient with newly diagnosed essential hypertension begins enalapril therapy. Which mechanism accounts for both the antihypertensive efficacy and the potential development of a persistent dry cough?

  1. Direct vasodilation of peripheral arterioles and selective stimulation of pulmonary mast cell degranulation
  2. Competitive antagonism of angiotensin II type 1 (AT1) receptors with secondary stimulation of AT2 receptors
  3. Inhibition of angiotensin-converting enzyme, preventing angiotensin II synthesis and blocking the degradation of bradykinin and substance P Correct answer.
  4. Blockade of calcium influx through L-type voltage-dependent calcium channels in vascular smooth muscle

Explanation

Enalapril is a prodrug converted to enalaprilat, which competitively inhibits angiotensin-converting enzyme (kininase II). This prevents conversion of angiotensin I to the potent vasoconstrictor angiotensin II, reducing systemic vascular resistance and aldosterone secretion. Because ACE also degrades pro-inflammatory kinins, its inhibition causes accumulation of bradykinin and substance P in pulmonary tissues, triggering the characteristic persistent dry cough.

Question 19Pharmacodynamic targets, class effects and therapeutic limits

What is the primary bactericidal mechanism of third-generation cephalosporins such as ceftriaxone?

  1. Irreversible binding to the 30S ribosomal subunit, inducing codon misreading and premature translation termination
  2. Covalent binding to penicillin-binding proteins (PBPs), inhibiting the transpeptidase cross-linking of peptidoglycan chains Correct answer.
  3. Inhibition of bacterial topoisomerase II (DNA gyrase) and topoisomerase IV, preventing DNA supercoiling
  4. Disruption of bacterial cell membrane phospholipid architecture, causing rapid leakage of intracellular electrolytes

Explanation

Ceftriaxone is a broad-spectrum beta-lactam cephalosporin that acylates transpeptidase enzymes (penicillin-binding proteins, especially PBP-1 and PBP-3) located on the outer surface of bacterial inner membranes. This prevents the final cross-linking transpeptidation step of peptidoglycan synthesis, weakening the bacterial cell wall and causing osmotic lysis mediated by endogenous autolysins. It possesses negligible activity against mammalian cell membranes.

Question 20Pharmacodynamic targets, class effects and therapeutic limits

How do benzodiazepines such as diazepam produce their sedative, anxiolytic, and anticonvulsant actions at the molecular level?

  1. Direct agonist activation of GABA-B metabotropic receptors coupled to G-protein inward potassium rectifiers
  2. Blockade of presynaptic reuptake transporters for gamma-aminobutyric acid (GAT-1), elevating synaptic GABA concentrations
  3. Direct opening of ligand-gated chloride channels independently of endogenous GABA neurotransmitter concentration
  4. Allosteric modulation of GABA-A receptors, increasing the frequency of chloride channel opening in response to GABA Correct answer.

Explanation

Benzodiazepines bind to a specific allosteric site at the alpha/gamma subunit interface of pentameric GABA-A receptor-chloride channel complexes. This binding induces a conformational shift that potentiates the affinity of GABA for its binding site, thereby increasing the opening frequency of the chloride channel and producing hyperpolarizing inhibitory postsynaptic potentials. Benzodiazepines do not act as direct channel agonists and do not increase channel open duration, which is characteristic of barbiturates.

Question 21Pharmacodynamic targets, class effects and therapeutic limits

Through which molecular target do second-generation sulfonylureas like glibenclamide stimulate insulin secretion from pancreatic beta cells?

  1. Inhibition of ATP-sensitive potassium (K-ATP) channels, causing membrane depolarization and calcium influx Correct answer.
  2. Inhibition of dipeptidyl peptidase-4 (DPP-4), prolonging the half-life of endogenous incretin hormones
  3. Activation of glucagon-like peptide-1 (GLP-1) receptors coupled to adenylate cyclase
  4. Peroxisome proliferator-activated receptor gamma (PPAR-gamma) activation, increasing insulin gene transcription

Explanation

Sulfonylureas bind specifically to the SUR1 regulatory subunit of ATP-sensitive inward-rectifier potassium (K-ATP) channels in the pancreatic beta-cell membrane. This inhibits potassium efflux, leading to cell membrane depolarization, opening of voltage-gated L-type calcium channels, calcium influx, and exocytotic release of stored preformed insulin granules. Because their action is independent of ambient glucose, they carry a distinct risk of hypoglycemia.

Question 22Pharmacodynamic targets, class effects and therapeutic limits

Which cellular mechanism is responsible for the positive inotropic effect of digoxin in the management of congestive heart failure?

  1. Stimulation of cardiac beta-1 adrenergic receptors, activating the adenylyl cyclase-cAMP-PKA pathway
  2. Direct agonism of myocardial ryanodine receptor type 2 channels, increasing sarcoplasmic reticulum calcium release
  3. Reversible inhibition of the sarcolemmal Na+/K+-ATPase pump, increasing intracellular sodium and subsequent calcium accumulation via the Na+/Ca2+ exchanger Correct answer.
  4. Inhibition of cardiac phosphodiesterase isoenzyme III, preventing intracellular breakdown of cyclic AMP

Explanation

Digoxin binds reversibly to the extracellular alpha subunit of the sarcolemmal sodium-potassium adenosine triphosphatase (Na+/K+-ATPase) pump, inhibiting active sodium extrusion. The resulting rise in intracellular sodium concentration reduces the electrochemical gradient driving the sodium-calcium exchanger (NCX), decreasing calcium extrusion and enhancing sarcoplasmic reticulum calcium loading. During subsequent action potentials, increased calcium is released to interact with troponin C, increasing myocardial contractility.

Question 23Pharmacodynamic targets, class effects and therapeutic limits

Which molecular enzymes do fluoroquinolones like ciprofloxacin target in Gram-negative and Gram-positive bacteria, respectively?

  1. Peptidyl transferase and 50S ribosomal subunit
  2. DNA-dependent RNA polymerase and topoisomerase I
  3. Dihydrofolate reductase and dihydropteroate synthase
  4. DNA gyrase (topoisomerase II) and topoisomerase IV Correct answer.

Explanation

Fluoroquinolones exert rapid concentration-dependent bactericidal activity by trapping cleavable enzyme-DNA complexes. They primarily inhibit bacterial DNA gyrase (topoisomerase II) in Gram-negative organisms, preventing negative supercoiling essential for DNA transcription and replication, while their primary target in Gram-positive organisms (such as Staphylococcus aureus and Streptococcus pneumoniae) is bacterial topoisomerase IV, which separates daughter DNA strands during replication.

Question 24Pharmacodynamic targets, class effects and therapeutic limits

In which nephron segment and via which transport mechanism does furosemide exert its potent diuretic action?

  1. Early distal convoluted tubule by inhibiting the Na+/Cl- cotransporter
  2. Thick ascending limb of the loop of Henle by reversibly inhibiting the apical Na+/K+/2Cl- cotransporter Correct answer.
  3. Late distal tubule and collecting duct by competitive antagonism of mineralocorticoid receptors
  4. Proximal convoluted tubule by non-competitive inhibition of carbonic anhydrase

Explanation

Furosemide is a loop diuretic that enters the tubular lumen via proximal organic acid secretion and binds reversibly to the chloride-binding site of the apical Na+/K+/2Cl- cotransporter (NKCC2) in the thick ascending limb of Henle's loop. By blocking reabsorption of these ions, it abolishes the corticomedullary osmotic gradient, producing brisk diuresis with marked urinary wasting of sodium, potassium, chloride, magnesium, and calcium.

Question 25Pharmacodynamic targets, class effects and therapeutic limits

Which electrophysiological action defines amiodarone as a Vaughan-Williams Class III antiarrhythmic agent?

  1. Blockade of outward delayed rectifier potassium currents (IKr), prolonging action potential duration and effective refractory period Correct answer.
  2. Blockade of slow inward L-type calcium channels, suppressing phase 0 depolarization in the SA and AV nodes
  3. Selective blockade of fast voltage-gated inward sodium channels, decreasing phase 0 depolarization velocity
  4. Direct stimulation of inward rectifying potassium channels, accelerating ventricular repolarization

Explanation

Although amiodarone displays electrophysiological properties of all four Vaughan-Williams classes, its predominant Class III action is the blockade of cardiac outward potassium channels (especially the rapid delayed rectifier current, IKr). This prolongs phase 3 repolarization, extending both the action potential duration and the effective refractory period across atrial, nodal, and ventricular myocardium, which appears on the surface electrocardiogram as QT interval prolongation.

Question 26Pharmacodynamic targets, class effects and therapeutic limits

Which ribosomal target is bound by macrolide antibiotics such as erythromycin and clarithromycin, and which pharmacokinetic interaction commonly complicates their use?

  1. Irreversible binding to the 30S ribosomal subunit preventing initiation; induction of hepatic glucuronosyltransferase
  2. Reversible binding to the 50S ribosomal subunit inhibiting translocation; potent inhibition of hepatic cytochrome P450 3A4 (CYP3A4) Correct answer.
  3. Binding to 16S rRNA within the 30S subunit; strong inhibition of renal P-glycoprotein without CYP involvement
  4. Binding to elongation factor EF-G on the 70S ribosome; potent induction of CYP2C9

Explanation

Macrolides bind reversibly to the 23S ribosomal RNA in the 50S subunit of bacterial ribosomes, blocking peptidyl transferase and inhibiting transpeptidation and translocation of nascent peptide chains. Both erythromycin and clarithromycin are potent mechanism-based (suicide) inhibitors of cytochrome P450 3A4 (CYP3A4), significantly elevating serum levels of co-administered CYP3A4 substrates like simvastatin, carbamazepine, and theophylline.

Question 27Pharmacodynamic targets, class effects and therapeutic limits

How does vancomycin inhibit bacterial cell wall synthesis in resistant Gram-positive pathogens such as MRSA?

  1. Inhibition of the transpeptidase active site through beta-lactam ring acyl substitution
  2. Binding to UDP-N-acetylmuramic acid pentapeptide inside the cytoplasm, halting lipid carrier transport
  3. High-affinity binding to the terminal D-alanyl-D-alanine moieties of peptidoglycan precursors, sterically blocking transglycosylation and transpeptidation Correct answer.
  4. Chelation of magnesium ions required for bacterial cell wall autolysin activation

Explanation

Vancomycin is a complex tricyclic glycopeptide that forms five hydrogen bonds with the terminal D-Ala-D-Ala dipeptide sequence of cell wall peptidoglycan precursors (UDP-MurNAc-pentapeptide). This caps the precursor and sterically hinders the transglycosylase enzyme from elongating the peptidoglycan backbone and transpeptidases from cross-linking adjacent polymers. Bacterial resistance (as in VRE) occurs when the terminal dipeptide is modified to D-alanyl-D-lactate or D-alanyl-D-serine.

Question 28Pharmacodynamic targets, class effects and therapeutic limits

Which intracellular pathway accounts for the potent anti-inflammatory and immunosuppressive actions of systemic glucocorticoids like prednisolone?

  1. Direct covalent inhibition of cell-surface leukotriene B4 receptors
  2. Binding to cytosolic glucocorticoid receptors, translocating to the nucleus to transrepress NF-kappa-B and induce lipocortin-1 (annexin A1), which inhibits phospholipase A2 Correct answer.
  3. Selective competitive antagonism of cyclooxygenase-2 (COX-2) catalytic active sites
  4. Inhibition of Janus kinase 3 (JAK3), blocking interleukin-2 signal transduction

Explanation

Glucocorticoid receptors influence transcription of multiple inflammatory and immune pathways. NF-kappa-B regulation and annexin-related effects are useful examples, not a complete explanation of every clinical action. Actual benefit, adverse effects and tapering decisions depend on the product, exposure and clinical context rather than receptor identification alone.

Question 29Pharmacodynamic targets, class effects and therapeutic limits

Which secondary messenger cascade is triggered upon activation of Gq protein-coupled receptors, such as alpha-1 adrenergic and vascular vasopressin V1 receptors?

  1. Inhibition of adenylyl cyclase, decreasing intracellular cyclic AMP and closing L-type calcium channels
  2. Activation of phospholipase C-beta (PLC-beta), cleaving PIP2 into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) Correct answer.
  3. Activation of adenylyl cyclase, stimulating cyclic AMP synthesis and activating protein kinase A (PKA)
  4. Direct opening of G-protein coupled inward-rectifying potassium channels (GIRK) via beta-gamma subunits

Explanation

Gq-coupled receptors activate membrane-bound phospholipase C-beta (PLC-beta). PLC-beta hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) into two second messengers: inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). Soluble IP3 diffuses to the endoplasmic/sarcoplasmic reticulum to open IP3-gated calcium channels, releasing stored calcium into the cytosol. Membrane-bound DAG, in concert with elevated calcium, activates protein kinase C (PKC) to phosphorylate target cellular proteins.

Question 30Pharmacodynamic targets, class effects and therapeutic limits

In the Rawlins and Thompson classification of adverse drug reactions, how does a Type A reaction differ from a Type B reaction?

  1. Type A reactions are augmented, dose-dependent, predictable pharmacological effects; Type B reactions are bizarre, non-dose-dependent, and idiosyncratic or immunologic Correct answer.
  2. Type A reactions are idiosyncratic, non-dose-dependent, and unpredictable; Type B reactions are predictable pharmacological extensions
  3. Type A reactions are chronic reactions that occur only after years of therapy; Type B reactions occur immediately upon drug discontinuation
  4. Type A reactions are teratogenic effects; Type B reactions are carcinogenic mutations

Explanation

The traditional type A category describes predictable extensions of pharmacological effects, often related to exposure. Type B describes reactions not readily predicted from that pharmacology, including some immune or idiosyncratic events. This teaching framework is not a guarantee that every type A event is mild, or that every type B event has no exposure relationship.

Question 31Pharmacodynamic targets, class effects and therapeutic limits

Which heterocyclic ring systems comprise the bicyclic core structure of penicillins versus cephalosporins?

  1. A 4-membered oxazolidinone ring in penicillins; a 5-membered isoxazole ring in cephalosporins
  2. A 5-membered pyrrolidine ring fused to an imidazole ring in penicillins; a piperazine ring in cephalosporins
  3. A 4-membered beta-lactam ring fused to a 5-membered thiazolidine ring in penicillins; a 4-membered beta-lactam ring fused to a 6-membered dihydrothiazine ring in cephalosporins Correct answer.
  4. A 6-membered pyridine ring fused to a pyrimidine ring in penicillins; a quinoline ring in cephalosporins

Explanation

The core pharmacophore of penicillins is 6-aminopenicillanic acid (6-APA), consisting of a 4-membered beta-lactam ring fused to a 5-membered sulfur-containing thiazolidine ring. Cephalosporins are based on 7-aminocephalosporanic acid (7-ACA), in which the 4-membered beta-lactam ring is fused to a 6-membered sulfur-containing dihydrothiazine ring. The larger ring in cephalosporins relieves ring strain, conferring greater chemical stability against certain beta-lactamases and acid degradation.

Question 32Pharmacodynamic targets, class effects and therapeutic limits

In the chemical classification of cardiac glycosides, what structural feature distinguishes a cardenolide (e.g., digitoxin from Digitalis) from a bufadienolide (e.g., from squill or toad venom)?

  1. Bufadienolides contain nitrogenous piperidine rings instead of steroid rings
  2. Cardenolides lack a steroid cyclopentanoperhydrophenanthrene aglycone nucleus
  3. Cardenolides have a 5-membered alpha,beta-unsaturated lactone ring at C-17; bufadienolides have a 6-membered doubly-unsaturated lactone (pyrone) ring at C-17 Correct answer.
  4. Cardenolides possess beta-D-glucose sugars, whereas bufadienolides contain no carbohydrate moieties

Explanation

Cardiac glycosides consist of a steroid aglycone (genin) linked to sugars. The aglycone features a cis-trans-cis ring conformation (A/B cis, B/C trans, C/D cis) and an unsaturated lactone ring attached at position C-17. Cardenolides (found in Digitalis purpurea and Strophanthus gratus) possess an alpha,beta-unsaturated 5-membered butyrolactone ring, whereas bufadienolides (found in Urginea maritima / squill and Bufo toad skin) feature a doubly-unsaturated 6-membered alpha-pyrone ring.

Question 33Pharmacodynamic targets, class effects and therapeutic limits

Which specific chemical moiety within the sesquiterpene lactone artemisinin (derived from Artemisia annua) is essential for its potent antimalarial activity against intra-erythrocytic Plasmodium falciparum?

  1. An alpha,beta-unsaturated carboxylic acid group
  2. A phenolic hydroxyl group at C-3
  3. An endoperoxide 1,2,4-trioxane bridge (C-O-O-C) Correct answer.
  4. A tertiary nitrogen atom within a pyridine ring

Explanation

Artemisinin contains an important endoperoxide structure associated with its antimalarial activity. Activation can generate reactive intermediates that affect multiple parasite components. The chemical feature does not establish a single exclusive molecular target, a universal clinical regimen or an appropriate treatment decision for an individual patient.

Question 34Pharmacokinetics, therapeutic monitoring and explicit calculation models

Phenytoin displays non-linear (Michaelis-Menten) elimination kinetics at therapeutic serum levels. What clinical implication does this have for dosing adjustments?

  1. Metabolic hepatic clearance enzymes become saturated, meaning small dose increments can produce disproportionately large rises in serum concentration and severe toxicity Correct answer.
  2. A constant percentage of drug is eliminated per hour regardless of serum concentration, making clearance predictable
  3. Renal tubular reabsorption increases linearly with dose, preventing toxic accumulation
  4. Steady-state concentration remains constant because increased doses induce rapid auto-elimination

Explanation

Phenytoin is eliminated predominantly by hepatic CYP2C9 and CYP2C19 enzymes whose capacity (Vmax) is reached within the therapeutic range (10 to 20 mcg/mL). Once these enzymes saturate, the kinetics shift from first-order (constant fraction eliminated) to zero-order (constant amount eliminated per unit time). Under zero-order conditions, small dosage increases can abruptly overwhelm clearance mechanisms, leading to steep, non-linear surges in serum levels and toxicity such as ataxia, nystagmus, and encephalopathy.

Question 35Pharmacokinetics, therapeutic monitoring and explicit calculation models

A patient with bipolar disorder maintained on lithium carbonate is prescribed hydrochlorothiazide for hypertension. What clinical risk arises from this combination, and why?

  1. Severe lithium sub-therapeutic failure due to thiazide-mediated osmotic urinary flushing
  2. Acute hypernatremic encephalopathy caused by competitive aldosterone antagonism
  3. Hypoglycemic coma because lithium stimulates pancreatic islet hypersecretion
  4. Life-threatening lithium toxicity because thiazides induce proximal tubular sodium and lithium reabsorption secondary to distal sodium depletion Correct answer.

Explanation

Lithium is a monovalent cation handled by the renal tubules identically to sodium. Thiazide diuretics inhibit the Na+/Cl- cotransporter in the distal convoluted tubule, causing natriuresis and volume contraction. In response to hypovolemia, the renin-angiotensin-aldosterone system upregulates compensatory sodium (and therefore lithium) reabsorption in the proximal convoluted tubule. This decreases renal lithium clearance by 25 to 50%, resulting in toxic accumulation manifesting as coarse tremors, ataxia, confusion, and seizures.

Question 36Pharmacokinetics, therapeutic monitoring and explicit calculation models

An antimalarial drug has an apparent volume of distribution (Vd) of 15 L/kg in a 70 kg adult (total Vd > 1000 L). What does this pharmacokinetic parameter indicate about the drug's physiological disposition?

  1. The drug is entirely restricted to the vascular plasma compartment with high plasma protein binding
  2. The drug is cleared exclusively by glomerular filtration without tissue uptake
  3. The drug undergoes extensive extravascular tissue distribution and intracellular sequestration relative to circulating plasma concentration Correct answer.
  4. The apparent volume of distribution is an experimental error because physical anatomical volume cannot exceed 42 liters

Explanation

The apparent volume of distribution (Vd = Dose / C0) is a theoretical proportionality constant relating the total amount of drug in the body to its concentration in blood plasma. Total body water in a 70 kg adult is approximately 42 L (plasma volume is 3 L). A Vd markedly exceeding total body water (such as 1000 L, seen with chloroquine, digoxin, and amiodarone) indicates that the drug is highly lipophilic and avidly bound to peripheral tissues (e.g., adipose, muscle, lysosomes), leaving very little free drug in the vascular compartment.

Question 37Pharmacokinetics, therapeutic monitoring and explicit calculation models

How does first-order drug elimination kinetics differ from zero-order elimination kinetics in clinical pharmacokinetics?

  1. In first-order kinetics, a constant amount of drug is cleared per unit time; in zero-order kinetics, a constant fraction is cleared
  2. Zero-order kinetics describes low-dose elimination, whereas first-order kinetics occurs when clearance pathways are saturated
  3. In first-order kinetics, elimination half-life increases as the plasma drug concentration increases
  4. In first-order kinetics, a constant fraction (percentage) of drug is eliminated per unit time, resulting in a constant elimination half-life independent of plasma concentration Correct answer.

Explanation

Most drugs at therapeutic concentrations exhibit first-order kinetics: the rate of elimination (-dC/dt = k * C) is directly proportional to plasma concentration. Because clearance is constant, a fixed percentage of drug is cleared per unit time, and the elimination half-life (t1/2 = 0.693 / k) remains invariant regardless of dose. In zero-order (saturation) kinetics, clearance pathways are saturated, so a constant absolute amount is eliminated per unit time (-dC/dt = k0), meaning half-life increases as concentration rises.

Question 38Pharmacokinetics, therapeutic monitoring and explicit calculation models

For a drug that exhibits a high hepatic extraction ratio (ER > 0.7, e.g., propranolol or lidocaine), what is the primary physiological determinant of its systemic clearance?

  1. Intrinsic hepatocellular enzyme activity (Clint) and plasma protein binding
  2. Gastrointestinal transit rate and gastric pH
  3. Glomerular filtration rate and renal tubular anion secretion
  4. Hepatic blood flow (perfusion-limited clearance) Correct answer.

Explanation

According to the well-stirred model of hepatic clearance (ClH = Q * [fup * Clint] / [Q + fup * Clint]), when a drug has a high extraction ratio (ER > 0.7), intrinsic clearance (fup * Clint) is much greater than hepatic blood flow (Q). The denominator simplifies to fup * Clint, reducing the equation to ClH ≈ Q. Thus, clearance is flow-limited (perfusion-limited): changes in liver blood flow (e.g., in heart failure, cirrhosis, or co-administration of beta-blockers) directly alter drug clearance, whereas changes in enzyme activity or protein binding have minimal effect.

Question 39Dosage forms, formulation behavior and responsible preparation

Which pharmaceutical mechanism explains how superdisintegrants such as croscarmellose sodium and sodium starch glycolate facilitate rapid tablet disintegration?

  1. Formation of an insoluble hydrophobic film that repels gastric fluid and fractures the tablet matrix
  2. Chemical reaction with gastric hydrochloric acid producing effervescent carbon dioxide bubbles
  3. Rapid water uptake through capillary action (wicking) accompanied by massive swelling and elastic recovery without forming viscous gel barriers Correct answer.
  4. Melting at physiological body temperature (37°C) through lipid phase transition

Explanation

Superdisintegrants like croscarmellose sodium (cross-linked sodium carboxymethylcellulose) and sodium starch glycolate (cross-linked potato starch ether) facilitate rapid disintegration at low concentrations (2-8%). They absorb aqueous fluid rapidly through porous capillary channels (wicking action) and exhibit dramatic swelling pressures (swelling up to 20-30 times their original dry volume) and recovery from plastic deformation, overcoming tablet binder forces to break the core apart without forming viscous gels.

Question 40Dosage forms, formulation behavior and responsible preparation

According to the Biopharmaceutics Classification System (BCS), what are the properties of a Class II drug, and what is the primary rate-limiting step for its systemic oral absorption?

  1. High solubility and high permeability; rate-limited by gastric emptying rate
  2. Low solubility and low permeability; rate-limited by hepatic first-pass extraction
  3. High solubility and low permeability; rate-limited by intestinal membrane transport rate
  4. Low solubility and high permeability; rate-limited by drug dissolution in gastrointestinal fluids Correct answer.

Explanation

Under the Biopharmaceutics Classification System (BCS), Class II drugs exhibit low aqueous solubility across the physiological pH range (pH 1.2 to 6.8) but high intestinal membrane permeability (fraction absorbed >= 85%). Because the drug readily permeates mucosal enterocytes once in solution, the overall rate and extent of systemic oral absorption are governed entirely by the in vivo dissolution rate. Formulation strategies like particle size reduction (micronization), solid dispersions, and lipid-based formulations enhance their bioavailability.

Question 41Dosage forms, formulation behavior and responsible preparation

In the physical pharmacy of dispersed systems, which characteristic distinguishes a flocculated suspension from a deflocculated suspension?

  1. Flocculated particles form loose, fluffy network aggregates (flocs) that settle rapidly, maintain high sediment volume, and easily redisperse with gentle shaking Correct answer.
  2. Flocculated particles form tightly packed, crystalline cakes at the container bottom that are impossible to resuspend
  3. Flocculated particles possess a very high zeta potential (> +30 mV), preventing all interparticulate collision
  4. Flocculated suspensions settle extremely slowly and produce clear supernatant liquid within minutes

Explanation

Controlled flocculation can create loose aggregates that settle relatively quickly but remain easier to redisperse than a compact hard cake. Sediment volume and redispersibility must be evaluated in the actual formulation. Flocculation alone does not guarantee permanent freedom from caking or accurate dosing without appropriate instructions.

Question 42Dosage forms, formulation behavior and responsible preparation

Which pharmacopoeial classification describes an ointment base composed entirely of white petrolatum, and what are its key clinical characteristics?

  1. Hydrocarbon (oleaginous) base; highly emollient, strongly occlusive, and completely insoluble in water Correct answer.
  2. Water-soluble base; easily washable, greaseless, and non-occlusive
  3. Absorption base; contains w/o emulsifiers and absorbs up to three times its weight in water
  4. Water-removable base; o/w emulsion that can be diluted with aqueous solutions

Explanation

White petrolatum (white soft paraffin) is the prototype of hydrocarbon (oleaginous) ointment bases. These bases consist of mixtures of liquid and solid hydrocarbons that are hydrophobic, anhydrous, and non-washable with water. When applied topically, they form a continuous, greasy, occlusive hydrophobic film over the stratum corneum that blocks transepidermal water loss (TEWL), providing prolonged emollient and skin-softening effects.

Question 43Dosage forms, formulation behavior and responsible preparation

Which rheological flow behavior is characterized by a reversible, time-dependent decrease in viscosity under constant shear stress, and why is it desirable in pharmaceutical suspensions?

  1. Dilatant (shear-thickening) flow; prevents particles from sedimenting during shaking
  2. Thixotropic flow; allows the suspension to liquefy upon shaking for easy pouring, then gradually regain high viscosity at rest to prevent particle settling Correct answer.
  3. Newtonian flow; ensures constant viscosity regardless of pouring speed or shaking agitation
  4. Plastic (Bingham) flow without hysteresis; guarantees immediate permanent thinning upon container opening

Explanation

Thixotropy describes reversible time-dependent structural breakdown under shear and recovery during rest. It can help a suspension pour or spread while retarding settling afterward. Product performance still depends on the actual vehicle, particles, recovery behavior and use conditions; the property alone does not guarantee perfect stability or injectability.

Question 44Dosage forms, formulation behavior and responsible preparation

Why do enteric coating polymers like cellulose acetate phthalate (CAP) and methacrylic acid-ethyl acrylate copolymers resist dissolution in the stomach but dissolve rapidly in the small intestine?

  1. They contain basic tertiary amine groups that are insoluble at acidic pH but protonate in alkaline bile
  2. They contain free carboxylic acid functional groups that remain un-ionized and insoluble in acidic gastric fluid (pH 1-3), but ionize to form soluble carboxylate salts at intestinal pH (pH >= 5.5-6.8) Correct answer.
  3. They are digested specifically by pancreatic lipase enzymes in the duodenum
  4. They undergo thermal phase dissolution triggered exclusively by intestinal peristalsis

Explanation

Relevant enteric polymers contain ionizable groups whose hydration and dissolution change with pH. Suitable formulations delay release in acidic gastric conditions and release later under their designed conditions. Different polymers and products have different thresholds, so the mechanism does not prove identical intestinal release or complete impermeability for every coating.

Question 45Dosage forms, formulation behavior and responsible preparation

Which pharmaceutical glass container type possesses the highest chemical resistance and lowest hydrolytic leaching, making it standard for packaging injectable parenteral solutions?

  1. Type II: De-alkalized treated soda-lime glass
  2. Type I: Highly resistant borosilicate glass Correct answer.
  3. Type III: Regular soda-lime silica glass
  4. Type NP: General-purpose non-parenteral glass

Explanation

Pharmacopoeias classify pharmaceutical glass into four distinct types based on hydrolytic resistance. Type I borosilicate glass contains boron oxide (B2O3) substituting for network alkali, conferring exceptional thermal and hydrolytic resistance with minimal leaching of sodium or alkali ions into solution. It is suitable for all parenteral packaging, including blood products, acidic, neutral, and alkaline aqueous injections.

Question 46Dosage forms, formulation behavior and responsible preparation

During rotary tablet compression, what is the manufacturing defect known as 'capping', and what is its primary mechanical cause?

  1. Uneven distribution of colorant across the tablet surface caused by dye migration during drying
  2. Adhesion of tablet material to the die wall resulting in chipped tablet edges, caused by insufficient lubricant
  3. Partial or complete detachment of the top or bottom crown of the tablet from the main body, caused by air entrapment and excessive punch speed during compression Correct answer.
  4. Fragmentation of the tablet into multiple horizontal layers caused by over-granulation

Explanation

Capping is a common tableting defect characterized by the partial or complete horizontal separation of the upper or lower crown of a tablet from the cylindrical body. It is caused primarily by air entrapment within the granule bed during rapid compression, excessive fine powders, inadequate binder, overly dry granules, or worn punch tips with deep concavity. When compression pressure is released upon tablet ejection, entrapped air expands elastically, shearing the crown.

Question 47Dosage forms, formulation behavior and responsible preparation

What are the three sequential stages of pharmaceutical lyophilization (freeze-drying) used in the manufacture of heat-labile biopharmaceuticals?

  1. Freezing, primary drying (ice sublimation under reduced pressure), and secondary drying (desorption of bound moisture) Correct answer.
  2. Evaporation, condensation, and crystallographic precipitation
  3. Atomization, droplet drying, and cyclone separation
  4. Precipitation, flocculation, and high-speed centrifugation

Explanation

Lyophilization (freeze-drying) is a dehydration process used for heat-sensitive drugs (such as vaccines, monoclonal antibodies, and cephalosporins). It proceeds through three stages: 1) Freezing: cooling below the eutectic point (or glass transition temperature, Tg') to crystallize the solvent; 2) Primary drying: chamber pressure is lowered below the triple point of water while heat is applied, causing ice to sublime directly into vapor; and 3) Secondary drying: temperature is raised under vacuum to desorb bound unfrozen water, reducing residual moisture to < 1-2%.

Question 48Pharmaceutical analysis, identity, stability and quality evidence

In a supplied typical reversed-phase HPLC comparison where ionization and other selectivity factors are controlled, which listed stationary/mobile-phase combination and polarity-related retention trend is expected?

  1. Polar stationary phase and non-polar mobile phase; non-polar compounds elute first
  2. Non-polar stationary phase and non-polar mobile phase; volatile compounds elute first
  3. Ionic stationary phase and gaseous mobile phase; high molecular weight solutes elute first
  4. Non-polar stationary phase (e.g., C18 octadecylsilane) and polar aqueous-organic mobile phase; polar compounds elute first, non-polar compounds elute last Correct answer.

Explanation

A typical reversed-phase system uses a relatively nonpolar stationary phase and an aqueous-organic mobile phase. Under the stated controlled comparison, stronger hydrophobic interaction tends to increase retention. Ionization, mobile-phase composition, specific interactions and other conditions can alter order, so polarity alone is not an unconditional predictor.

Question 49Pharmaceutical analysis, identity, stability and quality evidence

A quality control analyst assays a solution of a pure drug substance using UV-Visible spectrophotometry at 275 nm in a 1-cm path length quartz cuvette. The measured absorbance (A) is 0.600 and the molar absorptivity (epsilon) is 12,000 L/(mol*cm). According to the Beer-Lambert Law, what is the molar concentration of the drug?

  1. 2.0 x 10^-3 mol/L
  2. 5.0 x 10^-5 mol/L Correct answer.
  3. 7.2 x 10^-2 mol/L
  4. 1.2 x 10^-4 mol/L

Explanation

The Beer-Lambert Law states that Absorbance (A) = epsilon * b * c, where epsilon is the molar absorptivity in L/(mol*cm), b is the path length in cm, and c is the molar concentration in mol/L. Rearranging to solve for concentration gives c = A / (epsilon * b) = 0.600 / (12,000 * 1) = 0.00005 mol/L = 5.0 x 10^-5 mol/L. Spectrophotometric assays rely on this linear relationship within the optimal absorbance range of 0.2 to 0.8.

Question 50Pharmaceutical analysis, identity, stability and quality evidence

Which chemical degradation pathway is responsible for the breakdown of ester-containing drugs like acetylsalicylic acid (aspirin) and procaine in the presence of atmospheric moisture?

  1. Hydrolytic cleavage of the ester bond into carboxylic acid and alcohol components Correct answer.
  2. Photolytic dimerization
  3. Oxidative auto-deamination via free radical chain reaction
  4. Racemization around an asymmetric chiral center

Explanation

Esters (e.g., aspirin, procaine) and amides (e.g., lidocaine, paracetamol) are susceptible to hydrolytic degradation. Nucleophilic attack by water or hydroxyl ions on the electrophilic carbonyl carbon cleaves the ester linkage, converting acetylsalicylic acid into salicylic acid and acetic acid (which imparts a vinegary odor to degraded tablets). Formulations are protected against hydrolysis by moisture-impermeable packaging, inclusion of silica desiccants, and buffering to the pH of maximum stability.